Baricitinib in patients with moderate-to-severe atopic dermatitis and inadequate response to topical corticosteroids: results from two randomized monotherapy phase III trials

E. L. Simpson*, J. P. Lacour, L. Spelman, R. Galimberti, L. F. Eichenfield, R. Bissonnette, B. A. King, J. P. Thyssen, J. I. Silverberg, T. Bieber, K. Kabashima, Y. Tsunemi, A. Costanzo, E. Guttman-Yassky, L. A. Beck, J. M. Janes, A. M. DeLozier, M. Gamalo, D. R. Brinker, T. CardilloF. P. Nunes, A. S. Paller, A. Wollenberg, K. Reich

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

46 Scopus citations

Fingerprint Dive into the research topics of 'Baricitinib in patients with moderate-to-severe atopic dermatitis and inadequate response to topical corticosteroids: results from two randomized monotherapy phase III trials'. Together they form a unique fingerprint.

Medicine & Life Sciences